Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data from a new test discovered by the Company to assess the risk of cancer recurrence in patients diagnosed with soft tissue sarcomas (STS). Results were presented in a poster session at the Connective Tissue Oncology Society Annual Meeting, November 4-7, 2015 in Salt Lake City.
Read More →
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced the appointment of Federico A. Monzon, M.D. FCAP, to the newly created role of Chief Medical Officer. The Company also announced the appointment of Greg Schafer to Executive Director of Managed Care.
Read More →
inMediata, a healthcare payments and EDI company, is committed to solving payment problems for stakeholders in the healthcare industry.
When it comes to the healthcare reimbursement process, inMediata takes a different approach. The company is committed to solving payment problems for customers, and has built innovative healthcare technology solutions by listening and responding to the needs of their customers.
Read More →
Adoption of innovative fabric technology for healthcare worker and patient attire is growing, as more healthcare facilities forego traditional uniforms in an effort to better protect patients and staff from healthcare-associated infections (HAIs). As one indicator of this growth, Vestagen Technical Textiles reports that a variety of healthcare facilities have recently converted to its VESTEX protective uniforms.
Read More →
Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced the Company has secured payer contracts with national provider networks MultiPlan, Inc., FedMed, Inc. and Preferred Medical Claim Solutions, LLC to provide coverage of its DecisionDx™ assays. These networks together provide access to more than 120 million covered lives.
Read More →
The American Hospital Association (AHA) today announced it has exclusively endorsed Vestagen Technical Textiles, Inc.’s Vestex® Active Barrier Apparel, a protective fabric that combines fluid repellency and antimicrobial technologies embedded into health care worker scrubs, lab coats and jackets. AHA Solutions, Inc., a subsidiary of the AHA, awards the AHA Endorsement to products and services that help member hospitals and health care organizations achieve operational excellence.
Read More →
Trice Medical, which has developed technology that allows doctors to diagnose orthopedic injuries in their office, has raised an additional $6.5 million in a private equity financing.
The King of Prussia, Pa., medical device company has now raised a total of $18 million through the series B financing, which was led by Safeguard Scientifics Inc. (NYSE: SFE) of Wayne, Pa.
Read More →
